Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms in dopaminergic system and treatment-resistant schizophrenia.

Psychiatria Danubina - 1 Jun 2016

Terzić Tea, Kastelic Matej, Dolžan Vita, Plesničar Blanka Kores

Abstract excerpt

BACKGROUND: Dopaminergic system plays an important role in antipsychotic response. Functional single nucleotide polymorphisms (SNPs) can change dopamine receptor expression or dopamine disposition and thus influence response to antipsychotic treatment. SUBJECTS AND METHODS: 138 schizophrenia patients were stratified in the treatment-resistant and treatment-responsive group. Control group consisted of 94 healthy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Catechol O-Methyltransferase
Share to Pharmacogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Polymorphism, Single Nucleotide

Share to Receptors, Dopamine D1

Share to Receptors, Dopamine D2

Share to Receptors, Dopamine D3

Share to Schizophrenia

Source

Identifiers

PMID: 27287786

Genes

COMT
DRD1
DRD2
DRD3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms in dopaminergic system and treatment-resistant schizophrenia.PMID 27287786Read ↗

Association study between COMT, DRD2, and DRD3 gene variants and antipsychotic treatment response in Mexican patients with schizophreniaSemantic proximity Read ↗

Association of DRD2, DRD4 and COMT genes variants and their gene-gene interactions with antipsychotic treatment response in patients with schizophrenia.Semantic proximity Read ↗

Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients.Semantic proximity Read ↗

Association of Genetic Variants of Dopamine and Serotonin In Schizophrenia.Semantic proximity Read ↗

Genetic Variations in the Dopaminergic Signaling Pathways and Their Implications for Antipsychotics Pharmacogenetics.Semantic proximity Read ↗

DRD1 rs4532 polymorphism: a potential pharmacogenomic marker for treatment response to antipsychotic drugs.Semantic proximity Read ↗

Investigating DRD2 and HTR2A polymorphisms in treatment-resistant schizophrenia: a comparative analysis with other treatment-resistant mental disorders and the healthy state.Semantic proximity Read ↗

Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.Semantic proximity Read ↗

Risk Genes in Schizophrenia and Their Importance in Choosing the Appropriate Antipsychotic Treatment.Semantic proximity Read ↗

Clinical response to antipsychotic drug treatment: association study of polymorphisms in six candidate genes.Semantic proximity Read ↗

Exploring pharmacogenetic variation in a Bulgarian psychiatric cohort.Semantic proximity Read ↗

Genetic susceptibility to tardive dyskinesia among schizophrenia subjects: IV. Role of dopaminergic pathway gene polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.